Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GIS vs GSK✓SelectedUSD · GSKGIS vs GSK performance historyLatest closeAs of+3.65%11/20
Stock and ETF performance explorer

GIS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-30.2%
GSK return
+40.7%
Excess return
-70.8%
Maximum drawdown
-59.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.7%-0.1%+3.8%+3.7%
7D+4.1%-5.3%+9.5%+5.6%
30D+9.7%-3.7%+13.4%+10.8%
3M-8.1%-7.3%-0.8%-6.4%
6M+10.2%-4.2%+14.4%+11.2%
YTD-17.8%+0.9%-18.7%-18.5%
1Y-20.1%+7.3%-27.4%-21.9%
3Y-35.4%+52.7%-88.2%-42.5%
All-30.2%+40.7%-70.8%-38.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling